Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc is advancing innovative therapeutic solutions through its Enhanced Delivery Oligonucleotide platform, which has demonstrated significant potential for improving the delivery and efficacy of oligonucleotide therapeutics across diverse tissues. Positive preclinical results indicate that, under optimal conditions, there exists a potential for notable splicing correction improvements, with estimates suggesting a market reaction that could lead to substantial stock appreciation under successful clinical outcomes. The company’s ongoing pipeline developments, particularly with PGN-EDO51 and PGN-EDODM1, position it well for future growth in the neuromuscular and neurologic therapeutic areas, thereby establishing a positive outlook for its stock.

Bears say

PepGen Inc faces significant risks that contribute to a negative outlook, including potential unexpected safety issues related to its Enhanced Delivery Oligonucleotide (EDO) platform and the efficacy of its lead product, PGN-EDODM1, which may not meet expectations based on preclinical data. Additionally, regulatory uncertainties surrounding the approval pathways for its therapeutics could result in prolonged timelines, further hindering the company's prospects. Furthermore, the potential for negative news related to DMPK-targeting technology, even if unrelated to PepGen, poses an additional threat to investor sentiment and stock performance.

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Apr 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.